|
⚲
|
| Keyboard |
| Teehan Brendan
✚
|
|
|---|---|
| CIK # | 0001891900 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001891900] | |
| 4 | [0001891900] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pacira BioSciences Inc | |
| Teehan Brendan | |
| Acadia Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pacira BioSciences Inc PCRX
Common Stock
|
2026-02-11 | Grant | 51,714 | $0.00 | |
|
Pacira BioSciences Inc PCRX
Common Stock
|
2026-01-30 | Tax withheld | 5,182 | $20.54 | 106,438 |
|
Pacira BioSciences Inc PCRX
Common Stock
|
2025-12-31 | Grant | 402.27 | $10.76 | 4,328 |
|
Pacira BioSciences Inc PCRX
Stock Option (Right to Buy) · derivative
|
2025-02-04 | Grant | 99,500 | $26.59 | 2,645,705 |
|
Pacira BioSciences Inc PCRX
Common Stock
|
2025-02-01 | Grant | 54,000 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-11-19 | Sell | 10,329 | $16.81 | 173,630 |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-11-17 | Option exercise | 9,913 | ||
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-11-17 | Option exercise | 9,913 | ||
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2024-11-17 | Option exercise | 9,913 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2024-11-17 | Option exercise | 9,913 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-08-19 | Sell | 9,534 | $15.28 | 145,680 |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-08-16 | Grant | 5,024 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-08-16 | Grant | 13,629 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-05-02 | Sell | 3,477 | $16.94 | 58,900 |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-05-01 | Option exercise | 6,814 | ||
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2024-05-01 | Option exercise | 6,814 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-04-08 | Sell | 2,568 | $17.87 | 45,890 |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-04-05 | Option exercise | 5,024 | ||
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2024-04-05 | Option exercise | 5,024 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2024-03-27 | Sell | 5,140 | $17.90 | 92,006 |
| showing 20 of 67 most recent transactions | |||||